Building access to the Regenstrief Institute is restricted at least through July 5, 2020. More on our coronavirus precautions.
See our coronavirus precautions.
Drs. Callahan and Torke are leading a core of a national Alzheimer's research incubator.

Regenstrief researchers Christopher M. Callahan, M.D., and Alexia M. Torke, M.D., are leading the training core of a major national research incubator with the goal of improving healthcare and quality of life for people with Alzheimer’s disease and related dementias. Dr. Callahan and Dr. Torke will develop and coordinate a two-year junior career development award program to train researchers to conduct embedded pragmatic clinical trials in people living with dementia. The scientists trained will help to develop and test solutions to improve care for the growing population of people suffering from the disease.

Read more.

Related Influence

May 28, 2020 • Influence
Medical panel cites Regenstrief, IU School of Medicine study in recommendations
Findings from a study conducted by Regenstrief Institute and Indiana University School of Medicine research scientists were cited by the U.S. Preventive Services Task Force in its announcement that it can neither recommend nor oppose cognitive screening for older adults in primary care. The study, led by Nicole Fowler, PhD, MHSA, evaluated the pros and…
Continue Reading >
May 18, 2020 • Influence
Regenstrief president shares data exchange experience with Becker’s Hospital Review
Becker’s Hospital Review interviewed Regenstrief President and Chief Executive Officer Peter Embí, M.D., about the statewide data sharing effort to gather information on COVID-19. Dr. Embí played a major role to lead the collaborative effort among state agencies, academic institutions and the Indiana Health Information Exchange (IHIE) to create a visual dashboard displaying hospitalizations, demographics,…
Continue Reading >